MetLife: A Capital Return Story That Has Legs

Summary Points

*The company reported impressive Q3 2017 results that beat the top- and bottom-line estimates.

*One of the main reasons to be bullish on MET is the company's capital return story that keeps getting better.

*MET shares are a long-term buy at today's price.

In early 2016, I wrote an article on MetLife and stated that one of the main reasons to remain bullish about this insurer was the company's capital return story. I believe that MetLife's story has improved since that point in time so, in my opinion, long-term investors should continue to accumulate shares, even at today's price.